BioLife Sciences Company Top Management
BLFE Stock | USD 0.0001 0.00 0.00% |
BioLife Sciences employs about 3 people. The company is managed by 3 executives with a total tenure of roughly 7 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Evaluation of BioLife Sciences' management performance can provide insight into the firm performance.
Nika Jaksic Insider COO Director |
Colton Gooyer Insider Director Operations |
BioLife |
BioLife Sciences Workforce Comparison
BioLife Sciences is rated fourth in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is currently estimated at about 79,763. BioLife Sciences adds roughly 3.0 in number of employees claiming only tiny portion of all equities under Medical Instruments & Supplies industry.
BioLife Sciences Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioLife Sciences Price Series Summation is a cross summation of BioLife Sciences price series and its benchmark/peer.
BioLife Sciences Notable Stakeholders
A BioLife Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioLife Sciences often face trade-offs trying to please all of them. BioLife Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioLife Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Nika Jaksic | COO Director | Profile | |
Colton Gooyer | Director Operations | Profile | |
Justin Four | CEO Founder | Profile |
About BioLife Sciences Management Performance
The success or failure of an entity such as BioLife Sciences often depends on how effective the management is. BioLife Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioLife management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioLife management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature screening technology. Bio Life Sciences Corp. was incorporated in 2018 and is based in Mississauga, Canada. Biolife Sciences operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 3 people.
Please note, the presentation of BioLife Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioLife Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BioLife Sciences' management manipulating its earnings.
BioLife Sciences Workforce Analysis
Traditionally, organizations such as BioLife Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioLife Sciences within its industry.BioLife Sciences Manpower Efficiency
Return on BioLife Sciences Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 152.3K | |
Net Loss Per Executive | 152.3K |
Complementary Tools for BioLife Pink Sheet analysis
When running BioLife Sciences' price analysis, check to measure BioLife Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Sciences is operating at the current time. Most of BioLife Sciences' value examination focuses on studying past and present price action to predict the probability of BioLife Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Sciences' price. Additionally, you may evaluate how the addition of BioLife Sciences to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |